SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-10-17
👔
Moleculin Biotech, Inc.
@MBRX_InsiderForm 4 Filing: KLEMP WALTER V Surrenders for Taxes $18K of $MBRX
TAX WITHHOLDING
⚡ MATERIALITY: 3/10
corporate issuer
Moleculin Biotech, Inc.
Ticker: $MBRX
Transaction Value
$18K
Price/Share: $0.07
transaction date
2026-10-15
Shares: 256,159
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KLEMP WALTER V, holds the title of CEO and President at Moleculin Biotech, Inc..
On 2026-10-15, the insider transacted 256,159 shares.The shares were transacted at a weighted average price of $0.07 per share, resulting in a total market-relevant value of $18K.
Executive Summary Summary
KLEMP WALTER V (CEO and President) had withheld for taxes $18K of $MBRX
Post-Transaction Position: 723,181 shares
SEC Accession No: 0001437749-26-032865 (CIK: 938419)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.